[Developing principles for emergency prevention and treatment of Ebola fever] - PubMed (original) (raw)

. 1997 Jan-Feb;42(1):31-4.

[Article in Russian]

• PMID: 9103042

[Developing principles for emergency prevention and treatment of Ebola fever]

[Article in Russian]

V A Markin et al. Vopr Virusol. 1997 Jan-Feb.

Abstract

The authors validate the efficiency of pathogenetic approach to the development of urgent measures for the prevention and therapy of Ebola fever. The virus circulating in the body is to be blocked as soon as possible and the impaired functions and systems repaired. Therapy of Ebola fever should be based on the earliest possible and sufficiently prolonged administration of specific immunoglobulins in combination with pathogenetic drugs.

PubMed Disclaimer

Similar articles

• Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections.
  Kudoyarova-Zubavichene NM, Sergeyev NN, Chepurnov AA, Netesov SV. Kudoyarova-Zubavichene NM, et al. J Infect Dis. 1999 Feb;179 Suppl 1:S218-23. doi: 10.1086/514294. J Infect Dis. 1999. PMID: 9988187
• [EBOLA HEMORRHAGIC FEVER: DIAGNOSTICS, ETIOTROPIC AND PATHOGENETIC THERAPY, PREVENTION].
  Zhdanov KV, Zakharenko SM, Kovalenko AN, Semenov AV, Fisun AY. Zhdanov KV, et al. Klin Med (Mosk). 2015;93(9):5-11. Klin Med (Mosk). 2015. PMID: 27008735 Review. Russian.
• [Development and study of the properties of immunoglobulin against Ebola fever].
  Borisevich IV, Mikhaĭlov VV, Krasnianskiĭ VP, Gradoboev VN, Lebedinskaia EV, Potryvaeva NV, Timan'kova GD. Borisevich IV, et al. Vopr Virusol. 1995 Nov-Dec;40(6):270-3. Vopr Virusol. 1995. PMID: 8686265 Russian.
• Scale up the supply of experimental Ebola drugs.
  Brady O. Brady O. Nature. 2014 Aug 21;512(7514):233. doi: 10.1038/512233a. Nature. 2014. PMID: 25143079 No abstract available.
• [Research progress of prevention and treatment of Ebola virus infection].
  Wu W, Liu S. Wu W, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2014 Oct;34(10):1519-22. Nan Fang Yi Ke Da Xue Xue Bao. 2014. PMID: 25345954 Review. Chinese.

Cited by

• Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques.
  Olinger GG Jr, Pettitt J, Kim D, Working C, Bohorov O, Bratcher B, Hiatt E, Hume SD, Johnson AK, Morton J, Pauly M, Whaley KJ, Lear CM, Biggins JE, Scully C, Hensley L, Zeitlin L. Olinger GG Jr, et al. Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):18030-5. doi: 10.1073/pnas.1213709109. Epub 2012 Oct 15. Proc Natl Acad Sci U S A. 2012. PMID: 23071322 Free PMC article.
• Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody.
  Parren PW, Geisbert TW, Maruyama T, Jahrling PB, Burton DR. Parren PW, et al. J Virol. 2002 Jun;76(12):6408-12. doi: 10.1128/jvi.76.12.6408-6412.2002. J Virol. 2002. PMID: 12021376 Free PMC article.
• Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.
  Geisbert TW, Hensley LE, Larsen T, Young HA, Reed DS, Geisbert JB, Scott DP, Kagan E, Jahrling PB, Davis KJ. Geisbert TW, et al. Am J Pathol. 2003 Dec;163(6):2347-70. doi: 10.1016/S0002-9440(10)63591-2. Am J Pathol. 2003. PMID: 14633608 Free PMC article.
• Correlates of immunity to filovirus infection.
  Bradfute SB, Bavari S. Bradfute SB, et al. Viruses. 2011 Jul;3(7):982-1000. doi: 10.3390/v3070982. Epub 2011 Jun 27. Viruses. 2011. PMID: 21994766 Free PMC article. Review.
• Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys.
  Oswald WB, Geisbert TW, Davis KJ, Geisbert JB, Sullivan NJ, Jahrling PB, Parren PW, Burton DR. Oswald WB, et al. PLoS Pathog. 2007 Jan;3(1):e9. doi: 10.1371/journal.ppat.0030009. PLoS Pathog. 2007. PMID: 17238286 Free PMC article. Clinical Trial.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Medical

  • MedlinePlus Health Information